Anti-IFN21/ IFNA21/ IFN-alphaI functional antibody

Anti-IFN21/ IFNA21/ IFN-alphaI functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IFNA21/IFNA21 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0981-Ab-1/ GM-Tg-hg-SE0981-Ab-2Anti-Human IFNA21 monoclonal antibodyHuman
GM-Tg-rg-SE0981-Ab-1/ GM-Tg-rg-SE0981-Ab-2Anti-Rat IFNA21 monoclonal antibodyRat
GM-Tg-mg-SE0981-Ab-1/ GM-Tg-mg-SE0981-Ab-2Anti-Mouse IFNA21 monoclonal antibodyMouse
GM-Tg-cynog-SE0981-Ab-1/ GM-Tg-cynog-SE0981-Ab-2Anti-Cynomolgus/ Rhesus macaque IFNA21 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0981-Ab-1/ GM-Tg-felg-SE0981-Ab-2Anti-Feline IFNA21 monoclonal antibodyFeline
GM-Tg-cang-SE0981-Ab-1/ GM-Tg-cang-SE0981-Ab-2Anti-Canine IFNA21 monoclonal antibodyCanine
GM-Tg-bovg-SE0981-Ab-1/ GM-Tg-bovg-SE0981-Ab-2Anti-Bovine IFNA21 monoclonal antibodyBovine
GM-Tg-equg-SE0981-Ab-1/ GM-Tg-equg-SE0981-Ab-2Anti-Equine IFNA21 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0981-Ab-1/ GM-Tg-hg-SE0981-Ab-2; GM-Tg-rg-SE0981-Ab-1/ GM-Tg-rg-SE0981-Ab-2;
GM-Tg-mg-SE0981-Ab-1/ GM-Tg-mg-SE0981-Ab-2; GM-Tg-cynog-SE0981-Ab-1/ GM-Tg-cynog-SE0981-Ab-2;
GM-Tg-felg-SE0981-Ab-1/ GM-Tg-felg-SE0981-Ab-2; GM-Tg-cang-SE0981-Ab-1/ GM-Tg-cang-SE0981-Ab-2;
GM-Tg-bovg-SE0981-Ab-1/ GM-Tg-bovg-SE0981-Ab-2; GM-Tg-equg-SE0981-Ab-1/ GM-Tg-equg-SE0981-Ab-2
Products NameAnti-IFNA21 monoclonal antibody
Formatmab
Target NameIFNA21
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IFNA21 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0981-Ag-1Recombinant multi-species IFN21/ IFNA21/ IFN-alphaI protein
    CytokineGM-Tg-g-SE0981-Ag-1interferon, alpha 21 (IFNA21) protein


    Target information

    Target IDGM-SE0981
    Target NameIFNA21
    Gene ID3452,711252
    Gene Symbol and SynonymsIFN-alphaI,IFNA21,LeIF F,leIF-F
    Uniprot AccessionP01568
    Uniprot Entry NameIFN21_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000137080
    Target ClassificationN/A

    The target: IFNA21, gene name: IFNA21, also named as IFN-alphaI, LeIF F, leIF-F. This gene is a member of the alpha interferon gene cluster on the short arm of chromosome 9. Interferons are cytokines produced in response to viral infection that mediate the immune response and interfere with viral replication. The encoded protein is a type I interferon and may play a specific role in the antiviral response to rubella virus. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.